Science Explorer Back to mapMap
Discussion
Researcher · The Francis Crick Institute · United Kingdom

Thomas B.K. Watkins

Thomas B.K. Watkins publishes mostly in Cancer Research, Molecular Biology and Pulmonary and Respiratory Medicine, on topics such as Cancer Genomics and Diagnostics, RNA modifications and cancer and Cancer Immunotherapy and Biomarkers.

ORCID 0000-0001-7414-737X OpenAlex
World rank
#22,901
of 7,710,434 ranked researchers
Rank in United Kingdom
#1,659
of 367,258
Works
117
Citations
20k
Citations per work
174.8
h-index
38
i10-index 48Top 5.1% in Cancer Research
Thomas B.K. Watkins

What does Thomas B.K. Watkins research?

Thomas B.K. Watkins's work is mostly in Biochemistry, Genetics and Molecular Biology (51%), Medicine (26%), Immunology and Microbiology (7%).

Life Sciences: 68 works · 58.3% of their workBiochemistry, Genetics and Molecular Biology: 60 works · 50.9% of their workCancer Research: 31 works · 26.1% of their workMolecular Biology: 22 works · 19.1% of their workGenetics: 7 works · 5.7% of their workImmunology and Microbiology: 9 works · 7.4% of their workImmunology: 9 works · 7.4% of their workHealth Sciences: 30 works · 25.6% of their workMedicine: 30 works · 25.6% of their workPulmonary and Respiratory Medicine: 17 works · 14.3% of their workOncology: 13 works · 11.3% of their workEverything else: 19 works · 16.1% of their workTHEIR WORKThomas B.K.Watkins117works
Life Sciences58%Health Sciences26%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology6050.9%
    2. Immunology and Microbiology97.4%
    1. Medicine3025.6%
  3. Everything else1916.1%
  1. 1Cancer Research26% of their works
  2. 2Molecular Biology19% of their works
  3. 3Pulmonary and Respiratory Medicine14% of their works
  4. 4Oncology11% of their works
  5. 5Immunology7% of their works
  6. 6Genetics6% of their works

Research topics

Which keywords describe Thomas B.K. Watkins's research?

The keywords of their largest research topics: Targeted Therapy, Cancer Genomics, Mutational Signatures, Tumor Microenvironment, Cancer, ALK Inhibitors, EGFR Mutations and Immune Checkpoint Blockade.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Targeted Therapy642 topics
  2. Cancer Genomics511 topic
  3. Mutational Signatures511 topic
  4. Tumor Microenvironment202 topics
  5. Cancer142 topics
  6. ALK Inhibitors131 topic
  7. EGFR Mutations131 topic
  8. Immune Checkpoint Blockade131 topic
  9. PD-1 and PD-L1131 topic
  10. RNA methylation131 topic
  11. m6A-seq131 topic
  12. Cell Death71 topic
  13. Dendritic Cells71 topic
  14. Ferroptosis71 topic
  15. Immunity71 topic
  16. Long Noncoding RNAs71 topic
  17. RNA Regulation71 topic
  18. Adaptation51 topic
  19. Evolution51 topic

Where does Thomas B.K. Watkins work?

Thomas B.K. Watkins's main affiliation in the publication record is The Francis Crick Institute, United Kingdom.

How many publications and citations does Thomas B.K. Watkins have?

OpenAlex counts 117 works and 20,456 citations for Thomas B.K. Watkins, an h-index of 38, ranking #22,901 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Thomas B.K. Watkins. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.